Peer Review History
| Original SubmissionNovember 12, 2025 |
|---|
|
-->PONE-D-25-60540-->-->Research priorities for back pain: results from a James Lind Alliance approach-->-->PLOS One Dear Dr. Killingmo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.-->--> Your manuscript has been reviewed by two experts in the field. Both reviewers found the study to be important and the manuscript generally well written. However, they raised several substantive concerns that require attention before the manuscript can be considered for publication.-->--> I am therefore recommending Major Revision.-->--> In particular, I would like to draw your attention to the following key points, which both reviewers independently highlighted: - Methodological transparency: The manuscript should more clearly describe where the approach aligns with and diverges from the standard JLA methodology. The use of focus groups rather than surveys for generating research questions requires stronger justification. - Participant recruitment: Both reviewers noted the need for more detailed information on how patient representatives and clinicians were recruited, and how diversity was sought or achieved. - Evidence appraisal criteria: The process used to determine whether core questions had been "sufficiently addressed" by existing evidence needs to be more explicitly described. An appendix documenting the search strategy and appraisal rationale would strengthen transparency. - Strengths and limitations: The discussion should more thoroughly address potential biases in recruitment, question formulation, and the final prioritisation workshop, including group dynamics among the nine participants. Please also address all additional comments raised by each reviewer individually.-->--> When submitting your revision, please provide a point-by-point response to each reviewer's comments.-->--> I look forward to receiving your revised manuscript.-->--> Kind regards, Alessandro Rodolico Academic Editor, PLOS ONE-->--> Please submit your revised manuscript by Apr 23 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: [This study was supported by Foundation Dam (grant no. SDAM_UTV452311). Open access funding was provided by the Oslo Metropolitan University. Funding organisations had no part in the planning, performing, or reporting of the study.]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Partly Reviewer #2: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: N/A Reviewer #2: Yes ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: Comments are in the reviewer file that I uploaded - I cannot proceed without more text in this box so shall copy and text the file text. Thank you for asking me to peer review this interesting, well written and well structured manuscript. I recommend minor revisions prior to publication and outline these below. Introduction I appreciate the concise and appropriate content here. However, I think it would be worth expanding a little on the heterogeneity associated with back pain, and adding a couple of lines acknowledging the varied trajectories of back pain - acute, subacute and chronic back pain, and also any data on inequalities in impact of back pain, if you have these for Norway or Europe perhaps? Methods The introductory paragraph states that the method is ‘inspired by JLA’ but reporting is to patient and public involvement guidance. I’m wondering why the study is not reported according to the priority setting partnership guidance on the Equator site? Further, I note the study diverges a little from the JLA guidance – it would be helpful to clarify where it is aligned to JLA, and where it is not. For example, I don’t think a protocol was set or registered; I don’t think carers were involved… It would be helpful to have more explanation to me as a reviewer, and also within the text. I think potentially the most notable divergence is the generation of knowledge gaps/research topics by a relatively small set of focus groups, and not surveys – and you may well have good reasons, but they need more explanation and justification. This point is discussed under limitations on p24 (of the pdf manuscript that I have) but I think we need more earlier. I find it hard to see the as justification for a small number involved in setting questions instead of a survey. I’m looking at the JLA guidebook 2021 https://nihr.widen.net/s/zrmtvrknlk/jla-guidebook-version-10-march-2021 and on page 34 it does say focus groups can occur ‘as well as via a survey.’ I think we may understand the method as an adapted JLA approach or PSP more broadly. I think this point is important, as once the paper is published, I may wish to share it with colleagues, but I wouldn’t want them to think that it is necessarily JLA methodology/ for your paper to set a precedent. Broad generation of questions is surely important in JLA. Please do either correct my knowledge here, or address this issue in the manuscript. Recruitment for the focus groups – how did this occur exactly? This is obviously influential to the findings, so I think we need more detail on this for transparency. Setting the scope – I know that JLA is for health and healthcare research but there is rationale in the broad literature to also view back pain disability as influenced by social/political factors/structures such as workplace adaptations/interventions (or lack of), social security that addresses needs, broader policy responses, sources of marginalisation. It might be worth mentioning this within scope and then addressing the issue in the discussion. ‘Back pain’ is quite different to a more specific ‘disease’. Results These are interesting and a little exciting! It’s interesting to see so many with knowledge mobilisation/implementation roots. Were there any issues with language translation e.g. the term ‘tool’ occurred quite often? The English language can require a lot of context (I am sorry I do not know Norwegian) - were there any assumptions underpinning the meaning of ‘tool’ about what that was? Also is the term ‘non-specific’ being contested, or is something lost in translation? Discussion Within the summary line I think it would be worth inserting ‘in Norway’ just for clarity – you could also do this elsewhere. You might find more to discuss if also comparing with other literature and research recommendations made in guidelines for back pain. Would be good to have a subheading for strengths and limitations. I would contest the line ‘Despite best efforts to engage with all stakeholders’ – I think that given the broad nature and high prevalence of back pain, more organisations including those not dedicated to only back pain, could have facilitated involvement. I would be happy if you removed that phrase, but you could also address that issue more in the text. I agree with the issue you raise on representation – also you did not collect data on ethnicity or socioeconomic status – perhaps a recommendation for future work? I’m not sure I agree that the fourth limitation given is a limitation as such – it’s just the way things are. I would be happy for you to remove it, or discuss it as a point that is not a limitation – maybe see what the other reviewer, or editor, thinks? This is an optional point, but I would consider re-prioritising some of the space in the abstract, and expanding the conclusion, towards the main categories of findings including the very interesting knowledge implementation/mobilisation questions. Reviewer #2: Overall, this is an important and well‑conducted study, and the manuscript presents a generally clear and methodologically sound process. Below I provide several comments and suggestions aimed at improving clarity, transparency, and interpretability of the work. Abstract: Line 47: The statement that none of the core questions had been “sufficiently addressed” is unclear without an explanation of how “sufficiently” was defined. Providing a short description of the criteria (e.g., type of evidence required, reliance on existing systematic reviews, or methodological thresholds) would strengthen transparency. Abstract: The abstract reports only the top‑ranked research priority. Including a brief indication of the major thematic categories represented across the top 10 (e.g., lifestyle factors, healthcare organisation, diagnostics, prevention, patient‑centred care) would make the abstract more informative without compromising conciseness. Introduction: The introduction could more clearly articulate why end‑user involvement is especially important in back‑pain research. Given the condition’s subjective symptom profile, heterogeneous trajectories, and psychosocial influences, priorities set without patient involvement risk overlooking concerns most relevant to those living with back pain. Methods: More information is needed on how patient representatives were recruited. Clarifying whether recruitment was open, purposive, clinically mediated, or targeted would help readers assess representativeness and potential selection biases. Methods: Relatedly, the manuscript would benefit from a clearer description of how diversity among both patients and clinicians was sought or achieved (e.g., variation in age, sex, geography, clinical background, diagnostic history). Methods: Although the manuscript explains that evidence was evaluated to determine whether each core question had been “sufficiently addressed,” this process remains somewhat opaque. Including an appendix with the search strategy, screening approach, and rationale for retaining or excluding each core question would greatly enhance methodological transparency. Results: Some results raise questions about how evidence sufficiency was judged. For example, the classification of “What types of physical activity and exercise are appropriate for individuals with back pain?” as insufficiently answered may appear surprising given the extensive literature showing no clear superiority of specific exercise modalities. Again, an appendix documenting the evidence appraisal would resolve this and strengthen transparency. Results: One of the top 10 priorities concerns scoliosis (“risk of requiring spinal surgery”), which appears diagnostically narrower than the general back‑pain population described in the manuscript. It would be helpful to clarify why this topic remained within scope and how it aligns with the PSP’s stated population definition. Discussion: Given that the final top‑10 workshop involved nine participants, the Discussion could benefit from a short reflection on potential group dynamics, how differing views were managed, and what steps were taken to minimise dominance effects. Discussion: The Discussion could include a more explicit acknowledgement that PSP processes can be influenced by various forms of bias (e.g., in participant recruitment, question formulation, and decision‑making stages). ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
-->PONE-D-25-60540R1-->-->Research priorities for back pain: results from a James Lind Alliance approach-->-->PLOS One Dear Dr. Killingmo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 01 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:-->
--> If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Vincenzo De Luca Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Partly Reviewer #2: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: N/A Reviewer #2: N/A ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: No Reviewer #2: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: Thank you for asking me to review the revised manuscript which has improved and there is a more transparent methods section. I still have some concerns that are mainly focused on what the methodological framing of the study is – I do not find it to be a JLA study, rather a looser PSP. With some reframing in the manuscript, I think the study could be published as a PSP, but not as a JLA. The authors now note some of the divergent points in the manuscript and I have comments on some of these: • There is a divergence between the PSP study in the manuscript and that of a JLA in generating potential research questions through surveys – these can be paper, online etc., and using focus groups additionally, and this is not fully reflected in the manuscript as a major methodological point. • I am surprised to see the justification for not including informal carers as because they are rarely involved – this is contradicted by claims of the disabling nature of back pain and evidence on severe/high impact pain (and by my own clinical and research experience – may be a blind spot of this research team). At the minimum, a reference should be given here for that claim. • The points about the recommended research priorities made by reviewer 2 also show divergence from a JLA approach. I am surprised that the authors haven’t taken this on more in their revisions. I am not going to go into all of the divergent points, but this is why I think it is better to understand the study as a looser ‘PSP.’ I can see this research team have a similar study published as a JLA approach https://link.springer.com/article/10.1186/s41927-025-00588-7 and it is likely to be a contested point. I wonder if it would be best for the editor to contact the JLA directly with this query: https://www.jla.nihr.ac.uk/ Reviewer #2: The authors have addressed all of my previous comments satisfactorily. The revisions have improved the clarity, transparency, and interpretability of the manuscript, particularly with regard to methodological decisions and their underlying rationale. The authors now clearly justify their choices, acknowledge potential limitations and sources of bias inherent to the methodology, and appropriately discuss the implications of these for interpretation of the findings. Overall, the manuscript presents a technically sound and well‑reported study, and I consider it suitable for publication. ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. -->
|
| Revision 2 |
|
Research priorities for back pain: results from an adapted James Lind Alliance priority setting partnership PONE-D-25-60540R2 Dear Dr. Killingmo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Vincenzo De Luca Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.--> Reviewer #1: All comments have been addressed ********** -->2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Yes ********** -->3. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: N/A ********** -->4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes ********** -->5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes ********** -->6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: I contacted the JLA for advice regarding the phrasing used in studies that reported an adapted form of methods like your study and they suggested the following...We would typically see those referred to in publications using phrases like 'a priority setting project inspired by JLA methodology', or 'a priority setting project using adapated JLA methods'. I have chosen 'accept' here for the manuscript as I don't think this warrants further review and you have addressed the issues raised in the reviews, but do think you should go through the abstract and manuscript and ensure consistency with the phrasing of the methodology to 'adapted JLA.' ********** -->7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-25-60540R2 PLOS One Dear Dr. Killingmo, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vincenzo De Luca Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .